Activities of HHV-8 vIRF-1 in Virus Biology
Activities of HHV-8 vIRF-1 in Virus Biology
批准号:
8508375
负责人:
John Nicholas
金额:
$40.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2014-07-31
关键词:
AffinityApoptosisApoptoticB lymphoid malignancyBH3 DomainBindingBiologicalBiologyCell Cycle ArrestCell NucleusCell SurvivalCellsCessation of lifeCytoplasmDataDevelopmentDissectionDissociationEP300 geneEndothelial CellsFamilyFutureGenerationsGoalsHomologous GeneHuman Herpesvirus 8IRF1 geneIRF3 geneIndividualInfectionInterferonsInvestigationLaboratoriesLinkMapsMediatingMitochondriaMolecularMutateNoxaeNuclearNuclear Localization SignalNuclear ProteinsNuclear TranslocationPathway interactionsPeptidesPlayProductionProtein BindingProtein Binding DomainProtein FamilyProteinsReagentRefractoryRelative (related person)ReportingResearchRoleSignal TransductionSiteSpecific qualifier valueSpecificityStressTestingVariantViralViral ProteinsVirusVirus DiseasesVirus InhibitorsVirus Replicationbasebiological adaptation to stresscellular targetinggain of functionloss of functionlytic replicationmembernoveloverexpressionresponsetooltranscription factorviral interferon regulatory factorviral resistance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Human herpesvirus 8 (HHV-8) specifies four viral interferon regulatory factor homologues (vIRFs) that function to inhibit cellular IRFs in addition
to other components of cellular defense pathways that promote cell cycle arrest and apoptosis in response to virus infection. Cellular proteins targeted for inhibition by vIRF-1 include p53, ATM, GRIM19, Smad transcription factors, and p300/CBP transcriptional co-activators required for IRF-?mediated responses. This laboratory has identified an entirely novel class of interaction,
between vIRF-1 and stress-responsive, pro-apoptotic BH3-only proteins (BOPs) Bim and Bid, demonstrated to be inhibited by vIRF-1 binding, and other newly recognized BOP targets. Furthermore, we have identified partial localization of vIRF-1 to mitochondria, suggesting that vIRF-1 can inactivate BOPs directly at their site of action. vIRF-1- induced nuclear translocation of Bim represents a secondary, unique mode of inactivation. vIRF-1:BOP interaction is via the Bid-BH3B-related BOP-binding domain (BBD) of vIRF-1 (residues 170-187) and the BH3 domains of targeted BOPs. Both Bim and Bid are induced by HHV-8 lytic replication and Bim, at least, is a powerful inhibitor of virus production, suggesting that Bim and probably other BOPs need to be controlled effectively by HHV-8 for virus replication to occur. Indeed, vIRF-1 BBD-mediated interactions contribute specifically and significantly to promotion of HHV-8 productive replication and vIRF-1-mediated apoptotic inhibition. However, the precise contributions of each vIRF-1:BOP interaction and the significance of other vIRF-1:protein interactions in virus biology are at present unknown. Furthermore, our newly-identified mitochondrial localization of vIRF-1 has yet to be assessed functionally. This application proposes: identification of the molecular/specificity determinants of BOP/BH3 targeting and inhibition by vIRF-1 (Aim 1); molecular dissection and dissociation of other protein-binding and functional domains of vIRF-1 (Aim 2); establishing the contributions of each vIRF-1:protein interaction and mitochondrial-localized activity of vIRF-1 in the context of HHV-8 infection (Aim 3). The project comprises a comprehensive, yet focused analysis of an HHV-8 protein with a demonstrated positive role in virus replication and which provides a uniquely valuable tool to study the relative importance of multiple (vIRF-1-targeted) cellular defense pathways in virus biology. Information generated from this study could provide the basis for development of novel anti-viral therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
USP7 targeting by HHV-8 vIRFs
-
批准号:9883702
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2019
-
负责人:John Nicholas
-
依托单位:
USP7 targeting by HHV-8 vIRFs
-
批准号:10361554
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2019
-
负责人:John Nicholas
-
依托单位:
USP7 targeting by HHV-8 vIRFs
-
批准号:10581544
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2019
-
负责人:John Nicholas
-
依托单位:
HHV-8 vIRF interactions in the context of infection
-
批准号:8994365
-
项目类别:
-
资助金额:$17.62万
-
财政年份:2015
-
负责人:John Nicholas
-
依托单位:
HHV-8 vIRF interactions in the context of infection
-
批准号:9085244
-
项目类别:
-
资助金额:$21.14万
-
财政年份:2015
-
负责人:John Nicholas
-
依托单位:
Inhibitory targeting of HHV-8 vIL-6-related interactions.
-
批准号:8595304
-
项目类别:
-
资助金额:$20.51万
-
财政年份:2013
-
负责人:John Nicholas
-
依托单位:
BH3-only protein targeting by HHV-8
-
批准号:9193611
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2013
-
负责人:John Nicholas
-
依托单位:
BH3-only protein targeting by HHV-8
-
批准号:8537068
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2013
-
负责人:John Nicholas
-
依托单位:
Inhibitory targeting of HHV-8 vIL-6-related interactions.
-
批准号:8467210
-
项目类别:
-
资助金额:$17.62万
-
财政年份:2013
-
负责人:John Nicholas
-
依托单位:
BH3-only protein targeting by HHV-8
-
批准号:8601429
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2013
-
负责人:John Nicholas
-
依托单位:
BH3-only protein targeting by HHV-8
-
批准号:8786056
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2013
-
负责人:John Nicholas
-
依托单位:
Mitochondrial-localized activities of HHV-8 vIRF-1
-
批准号:8282293
-
项目类别:
-
资助金额:$24.6万
-
财政年份:2012
-
负责人:John Nicholas
-
依托单位:
Mitochondrial-localized activities of HHV-8 vIRF-1
-
批准号:8413784
-
项目类别:
-
资助金额:$20.5万
-
财政年份:2012
-
负责人:John Nicholas
-
依托单位:
Role of vGPCR in HHV-8 productive replication
-
批准号:8107969
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2010
-
负责人:John Nicholas
-
依托单位:
Bim regulation by HHV-8 vIRF-1
-
批准号:7554328
-
项目类别:
-
资助金额:$18.45万
-
财政年份:2008
-
负责人:John Nicholas
-
依托单位:
Bim regulation by HHV-8 vIRF-1
-
批准号:7667943
-
项目类别:
-
资助金额:$22.14万
-
财政年份:2008
-
负责人:John Nicholas
-
依托单位:
HHV-8 vGPCR Signaling in Virus Biology
-
批准号:7228721
-
项目类别:
-
资助金额:$16.38万
-
财政年份:2007
-
负责人:John Nicholas
-
依托单位:
HHV-8 vGPCR Signaling in Virus Biology
-
批准号:7343218
-
项目类别:
-
资助金额:$19.68万
-
财政年份:2007
-
负责人:John Nicholas
-
依托单位:
P-3:Viral Chemokine signalling in HHV-8 infection
-
批准号:7065941
-
项目类别:
-
资助金额:$17.75万
-
财政年份:2005
-
负责人:John Nicholas
-
依托单位:
ROLE OF VIL-6 IN PRIMARY EFFUSION LYMPHOMAS
-
批准号:6514205
-
项目类别:
-
资助金额:$18.39万
-
财政年份:2000
-
负责人:John Nicholas
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: